Carregant...

Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs

RATIONALE: Results from clinical trials in patients with severe eosinophilic asthma have demonstrated that mepolizumab is well tolerated and is associated with improved asthma control as evidenced by reductions in both exacerbations and maintenance oral corticosteroid use, and improvements in lung f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Asthma Allergy
Autors principals: Llanos, Jean-Pierre, Ortega, Hector, Bogart, Michael, Packnett, Elizabeth R, Manjelievskaia, Janna, Bell, Christopher F, Hahn, Beth
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996212/
https://ncbi.nlm.nih.gov/pubmed/32099413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S236609
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!